Essential Tremor and Other Tremor Types

Essential Tremor Mechanisms

• Olivocerebellar dysfunction: Abnormal activity in the inferior olivary nucleus and cerebellar circuits results in loss of normal inhibitory control over thalamic relay neurons. Neuroimaging studies demonstrate altered cerebellar connectivity and increased metabolic activity in the cerebellum and red nucleus. The thalamus acts as a relay station, and disruption of cerebellar-thalamic-cortical loops leads to oscillatory instability at frequencies of 4–12 Hz (typically 8–10 Hz).

• Thalamic pacemaker theory: The ventral intermediate nucleus (VIM) and ventral oral nucleus of the thalamus exhibit intrinsic oscillatory properties mediated by altered T-type calcium channel function and gap junction coupling. Neuronal populations in these regions fire rhythmically, generating tremor frequencies. Deep brain stimulation targeting VIM disrupts these oscillations and effectively suppresses tremor.

• Cerebellar-purkinje cell pathology: Postmortem studies reveal reduced dendritic spine density on Purkinje cells and abnormal cerebellar circuitry. Loss of GABAergic inhibition within cerebellar nuclei enhances excitatory output to the inferior olive, perpetuating oscillatory activity.

Parkinson's Disease Tremor (Rest Tremor)

• Basal ganglia dysfunction: Dopaminergic denervation in the substantia nigra pars compacta disrupts the balance between direct (facilitatory) and indirect (inhibitory) motor pathways. Excessive inhibitory output from the globus pallidus interna to the thalamus generates characteristic 4–6 Hz rest tremor.

• Altered striatal dopamine: Loss of dopaminergic neurons reduces D1-mediated facilitation of the direct pathway and removes D2-mediated inhibition of the indirect pathway. This imbalance produces rhythmic discharge in thalamic relay neurons.

Other Tremor Types

• Physiologic tremor: Enhanced by increased sympathetic tone (via beta-adrenergic receptor activation) and mechanical oscillations of limbs; frequency 8–12 Hz.
• Dystonic tremor: Occurs within regions affected by dystonia; mediated by abnormal pattern of muscle co-contraction and disrupted motor control circuits.
• Orthostatic tremor: Rapid (14–18 Hz) burst of activity in leg muscles triggered by standing; pathophysiology incompletely understood but may involve proprioceptive sensory feedback loops.

Essential Tremor

• Genetic predisposition: Autosomal dominant inheritance with incomplete penetrance; mutations in TENM4, FUS, GRP37L1, and other loci identified in genome-wide association studies. Most ET cases remain genetically unexplained.
• Advancing age: Tremor onset often in second to third decade but increases in prevalence and severity with age.
• Alcohol sensitivity: Paradoxically, alcohol temporarily suppresses tremor in 50–65% of patients (highly specific for ET); this "alcohol-responsive tremor" is a diagnostic hallmark.
• Stress and emotion: Physical and emotional stress exacerbate tremor amplitude.
• Caffeine and sympathomimetic agents: Enhance postural tremor.

Parkinson's Disease Tremor

• Age-related neurodegeneration: Loss of dopaminergic neurons in substantia nigra pars compacta.
• Genetic mutations: LRRK2, SNCA, PINK1, PARK2, and other monogenic and oligogenic forms.
• Environmental toxins: MPTP (in drug users), herbicides, pesticides.
• Smoking history: Paradoxically protective association noted in some studies.

Secondary Tremor Causes

Medications Causing Tremor

• Sympathomimetics: Pseudoephedrine, epinephrine, albuterol
• Corticosteroids: Long-term use
• Lithium: Narrow therapeutic window; fine tremor common at therapeutic levels
• Antipsychotics/antidepressants: SSRIs, newer antipsychotics (akathisia-related tremor)
• Caffeine, theophylline: Methylxanthines
• Valproic acid: Paradoxically used to treat tremor but can cause postural tremor
• Amiodarone: Beta-adrenergic effects

Essential Tremor

• Cardinal symptom—Bilateral postural tremor: Tremor appears or worsens when arms are outstretched against gravity (hands extended forward, fingers spread). Amplitude typically 5–10 mm, frequency 8–10 Hz. Tremor is present throughout the postural hold, unlike physiologic tremor which appears transiently.

• Kinetic tremor: Tremor worsens with intentional movement toward a target (e.g., finger-to-nose test). Distinguishes ET from pure postural tremor. Becomes more pronounced as the hand approaches the target (terminal tremor).

• Functional impairment:
• Difficulty with fine motor tasks (handwriting, eating, drinking from a cup, buttoning clothes)
• Speech affected in 25% of cases (vocal tremor produces quavering voice; laryngeal tremor)
• Head tremor (20–30% of cases; "yes-yes" or "no-no" tremor)
• Difficulty maintaining stable posture or gait

• Absence of rest tremor: Tremor disappears completely at rest (hands relaxed in lap or on table), distinguishing ET from Parkinsonian rest tremor. This is a cardinal diagnostic feature.

• Alcohol response: 50–65% of patients report dramatic suppression of tremor within 15–30 minutes of alcohol ingestion, lasting 2–6 hours. This is highly specific for ET but not universally present. Patients may self-medicate, leading to alcohol dependence.

• Psychosocial impact: Embarrassment, social withdrawal, occupational disability; tremor may limit career choices or advancement. Anxiety about tremor paradoxically worsens tremor (negative feedback loop).

• Age of onset: Typically in second to third decade or after age 40. Bimodal age distribution (younger and older onset peaks). Tremor typically slowly progressive over years to decades, but rate of progression varies widely.

Parkinson's Disease Tremor

• Rest tremor (4–6 Hz): Tremor present when limbs are fully relaxed and supported against gravity (arms in lap). Classic "pill-rolling" tremor of the thumb and fingers in supinated hand. Tremor suppresses with voluntary movement but reappears when movement is held.

• Associated Parkinsonian features:
• Bradykinesia: Slowed movement, reduced amplitude, difficulty initiating action
• Rigidity: "Lead pipe" (uniform throughout range of motion) or "cogwheel" (superimposed tremor on rigidity)
• Postural instability: Loss of righting reflexes, forward-flexed posture, retropulsion
• Reduced arm swing, masked facies, hypophonia

• Postural/kinetic tremor may occur: Some patients develop low-amplitude postural tremor superimposed on rest tremor.

Physiologic Tremor

• Fine, rapid tremor (8–12 Hz) visible only when postural hold is stressed (extended arms with narrow paper strip between fingers).
• Enhanced by: Caffeine, anxiety, fatigue, hypoglycemia, hyperthyroidism, sympathomimetics.
• No functional impairment in most cases.

Dystonic Tremor

• Irregular, jerky tremor within a body part affected by dystonia (e.g., focal hand dystonia in musicians).
• Tremor only in dystonic limb, ceases with dystonic posture or rest.
• Often task-specific: occurs only during particular motor activity (writing, playing instrument).

Cerebellar/Intention Tremor

• Low-frequency tremor (2–5 Hz) that is minimal or absent at rest.
• Worsens dramatically with purposeful movement, particularly as hand approaches target (intention component).
• Associated signs: Dysmetria (past-pointing on finger-to-nose), dysdiadochokinesia (impaired rapid alternating movements), ataxic gait, nystagmus, dysarthria.
• Causes: Demyelination (MS), cerebellar stroke, ataxia-telangiectasia, spinocerebellar degenerations, cerebellar tumor.

Orthostatic Tremor

• Rapid tremor (14–18 Hz) in legs triggered specifically by standing, relieved by sitting or walking.
• Patients report unsteadiness or shakiness only when upright and immobile.
• Surface electromyography (EMG) shows synchronous bursting in leg muscles.

Rubral Tremor (Midbrain/Red Nucleus Involvement)

• Combination of rest, postural, and kinetic tremor (slow, 2–5 Hz).
• Large amplitude, often disabling.
• Associated with midbrain stroke, trauma, multiple sclerosis.

• Rest + postural + kinetic tremor; slow frequency (2–5 Hz).
• Associated with brainstem or cerebellar pathology.

Task-Specific Tremor

• Tremor occurs only during specific activities (writing tremor in primary writing tremor, occupational tremor in musicians).
• Absent during other purposeful movements and at rest.

Wilson's Disease—"Wing-Beating Tremor"

• Rapid, irregular, large-amplitude tremor of outstretched arms with wrist extension ("wing-beating" or "asterixis-like" appearance).
• Associated with Kayser-Fleischer rings (copper deposition in Descemet's membrane), hepatic dysfunction, psychiatric symptoms.

Medication-Induced and Toxic Tremors

• Lithium: Fine postural tremor even at therapeutic levels; coarser tremor at toxicity.
• Stimulants (amphetamines, theophylline): Fine postural tremor exacerbated by anxiety.
• Alcohol withdrawal: Coarse postural tremor, associated with autonomic hyperactivity (tachycardia, hypertension, diaphoresis, agitation).
• Hepatic encephalopathy: Asterixis (lapses in posture; flapping tremor with wrist extension); non-rhythmic.

Clinical Examination—Tremor Classification

Diagnostic Tests for Essential Tremor

1. 1.Clinical diagnosis (gold standard):

• Tremor Rating Scale (TRS) quantifies severity
• Fahn-Tolosa-Marin Tremor Rating Scale (most widely used): scores postural tremor, kinetic tremor, rest tremor, and functional disability
• Must demonstrate bilateral postural/kinetic tremor with functional impairment and absence of rest tremor (or minimal rest tremor)
• Alcohol response history (though not required for diagnosis)

1. 1.Accelerometry and surface EMG:

• Accelerometer worn on hand quantifies tremor frequency and amplitude objectively
• Surface EMG shows synchronous, rhythmic bursting in antagonist muscles (alternating pattern)
• Helps distinguish ET from other tremor types but not routinely required for diagnosis

1. 1.Laboratory studies (rule out secondary causes):

• Thyroid function tests (TSH, free T4): Exclude hyperthyroidism
• Metabolic panel: Electrolytes, glucose, calcium
• Liver function tests: Assess for hepatic disease, Wilson's disease
• Ceruloplasmin and serum copper: Indicated if age <40, family history of liver disease, or associated neuropsychiatric symptoms (Wilson's disease)
• 24-hour urine copper: More sensitive for Wilson's disease; >75 μg/24 h suggestive
• Medication review: Screen for tremor-inducing drugs
• Toxicology: Alcohol, stimulants, mercury (occupational history)

1. 1.Neuroimaging (typically NOT required for uncomplicated ET):

• MRI brain: Obtained if:
• Atypical features (asymmetric, prominent rest tremor, associated parkinsonism)
• Acute tremor onset
• Focal neurologic signs
• Suspected secondary cause (stroke, MS, tumor)
• Evaluating for deep brain stimulation candidacy
• Normal imaging in typical ET; may show cerebellar atrophy in long-standing disease

1. 1.PET/SPECT imaging:

• DAT-SPECT or [18F]-fluorodopa PET: Shows preserved dopamine transporter in ET (distinguishing from Parkinson's disease, where uptake is reduced in nigrostriatum)
• Useful when diagnosis between ET and Parkinson's is uncertain
• Not routinely performed; reserved for diagnostic dilemmas

Step 1 — Decide whether to treat at all

• No pharmacotherapy: Mild tremor without functional or social impairment requires only reassurance, review and withdrawal of tremorgenic drugs (sympathomimetics, lithium, valproate, stimulants), and reduction of caffeine. Occupational therapy with weighted utensils, wrist weights, and wide-grip pens is appropriate adjunctive care.
• Situational tremor (public speaking, performance): an as-needed dose of a non-selective beta blocker such as propranolol taken before the event is reasonable.

First-line therapy (American Academy of Neurology evidence-based guideline on essential tremor, Level A)

• Non-selective beta blockers: propranolol is the prototype. Blockade of peripheral beta-2 receptors on intrafusal muscle-spindle fibers dampens the mechanical-reflex component of tremor; efficacy tracks with beta-2, not beta-1, blockade — which is why cardioselective agents are weaker. Titrate to effect; long-acting formulations aid adherence.
• Primidone: barbiturate-class anticonvulsant metabolized to phenobarbital and PEMA; enhances GABA-A–mediated inhibition in cerebellar-thalamic circuits. Start at a very low bedtime dose (e.g., 25 mg) to avoid the acute toxic reaction.
• Combination of propranolol plus primidone is standard when monotherapy gives partial benefit.

Definitive therapy for medication-refractory, disabling tremor

• Ventral intermediate (VIM) thalamic deep brain stimulation — usually unilateral first, contralateral to the dominant hand; adjustable and reversible.
• MRI-guided focused ultrasound thalamotomy — incisionless lesioning, FDA-approved, typically unilateral.

Avoid / contraindicated

• Propranolol: asthma and bronchospastic COPD, sinus bradycardia, high-grade AV block, decompensated heart failure; caution in insulin-treated diabetes (masks hypoglycemic warning signs). Do not stop abruptly in coronary disease.
• Levodopa and anticholinergics: ineffective in ET — their use is a management distractor.
• Alcohol: symptomatically effective but never recommended as therapy given dependence risk.

Complications of the disease

• Progressive functional disability: worsening kinetic tremor makes eating, drinking, writing, and grooming impossible without assistance; signaled by spilling liquids and abandoning handwriting.
• Psychosocial morbidity and alcohol misuse: because ethanol transiently suppresses tremor, patients self-medicate; escalating daily intake or morning drinking signals dependence. Abrupt cessation risks withdrawal seizures and delirium tremens — a medical emergency.
• Gait ataxia and falls: long-standing ET involves cerebellar circuitry; tandem-gait impairment on exam is the signal.
• Emergence of rest tremor, bradykinesia, or asymmetry: suggests coexisting or evolving Parkinson's disease and should prompt re-evaluation, not simple dose escalation.

Complications of pharmacotherapy

• Propranolol: bradycardia, hypotension, fatigue, and bronchospasm in asthmatics — an emergency; masked hypoglycemia in insulin users; abrupt withdrawal causes rebound tachycardia and can precipitate angina or infarction in coronary disease.
• Primidone: the acute toxic reaction — vertigo, nausea, vomiting, ataxia, and profound sedation after the first dose or two; avoided by low bedtime initiation. Chronic use produces sedation, falls in the elderly, hepatic enzyme induction (reduced warfarin and oral contraceptive efficacy) via the phenobarbital metabolite, and withdrawal seizures if stopped abruptly — an emergency.
• Topiramate: paresthesias, weight loss, word-finding difficulty, nephrolithiasis, non-anion-gap metabolic acidosis, and acute angle-closure glaucoma (painful red eye with blurred vision, typically in the first weeks) — an ophthalmologic emergency requiring immediate drug discontinuation.
• Benzodiazepines: sedation, falls, tolerance, dependence.
• Botulinum toxin: dose-dependent hand or finger weakness with limb injection; dysphagia and breathy hypophonia with laryngeal injection, with aspiration risk.

Complications of procedures

• DBS: intracranial hemorrhage at lead placement (new focal deficit or depressed consciousness postoperatively — an emergency), hardware infection or erosion, lead migration, stimulation-induced dysarthria, paresthesias, and gait imbalance; some patients develop habituation with waning benefit.
• Focused ultrasound thalamotomy: persistent paresthesias and gait ataxia; the lesion is irreversible.

• The classic stem: an older adult with a bilateral, symmetric action tremor of the hands that worsens when holding a coffee cup, improves dramatically after one or two drinks, and runs in the family. That triad is essential tremor until proven otherwise.
• The single most tested discriminator: ET tremor appears with posture and action and vanishes at rest; Parkinson's tremor is present at rest, asymmetric, pill-rolling, and damps with voluntary movement. Handwriting follows suit — a large tremulous scrawl in ET versus micrographia in Parkinson's.
• Best next step in a patient under 40 with new tremor: serum ceruloplasmin and slit-lamp exam for Kayser-Fleischer rings to exclude Wilson disease, before labeling the tremor essential. In any adult, check TSH.
• Head ("yes-yes"/"no-no") and voice tremor belong to ET; Parkinson's classically produces jaw and chin tremor, not titubation. Isolated head or voice tremor is best treated with botulinum toxin.
• First-line drugs are propranolol and primidone (AAN evidence-based guideline). If the stem gives asthma or COPD, propranolol is out — choose primidone. If the stem gives an elderly patient at fall risk or a heavy sedation concern, favor propranolol.
• Primidone is metabolized to phenobarbital; the tested adverse event is the acute toxic reaction (vertigo, nausea, ataxia) after the first dose, prevented by low bedtime initiation.
• Refractory, disabling tremor → VIM thalamic DBS (or focused ultrasound thalamotomy). The target is the ventral intermediate nucleus of the thalamus — memorize it.
• Common distractors: giving levodopa or an anticholinergic for ET (ineffective — ET is not a dopaminergic disorder, and a normal DAT scan confirms this); ordering routine MRI for a typical ET presentation; and calling asterixis a tremor — it is a negative myoclonus of hepatic encephalopathy.